hotspot -WSS

hotspot

author：hotspot 2025-09-30 23:05:48 - browse：7929

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Medicare Advantage 2025 payments will dip, Biden administration says

WSS

Former reverend arrested for allegedly killing 8

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Truvian presents data for its desktop blood

Democrats decry new health bill for going easy on private equity

Republican states more likely to report Covid vaccine side effects

Democrats decry new health bill for going easy on private equity

knowledge

hotspot

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Florida Supreme Court upholds state's abortion ban

Psychedelics group wrestles with new pharma identity

The haunting brain science of long Covid

Dobbs anniversary: the lost opportunity of abortion as health care

Will the FTC rein in IQVIA's health data empire?

Trump demands the U.S. pay no more for drugs than other countries … again

CDC Director Mandy Cohen on transparency, trust, and health

Medical records are filled with copy

The battle over 'scope creep' and who gets to be called 'doctor'

hotspot

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

STAT Report: Patient voices and perspectives

Trial using CRISPR to edit HIV out of cells disappoints

Harvard scientists, with Google, unveil the most detailed brain map ever

What causes rare myocarditis in young men after Covid vaccines?

U.K. decision on ALS drug has neurologists, advocates up in arms

focus

knowledge

focus

leisure time